Profil
Karen M.
King is currently the Global Head-Investor Relations at Medline, Inc. since 2024.
Formerly, Ms. King was Vice President-Investor Relations at Perdoceo Education Corp.
from 2005 to 2008, Vice President-Investor Relations at Hospira, Inc. from 2014 to 2015, VP-Investor Relations & Corporate Communications at LivaNova Plc from 2016 to 2018, and SVP-Global Investor Relations & Communications at Alcon AG from 2018 to 2022.
Education includes undergraduate studies at Indiana University.
Aktive Positionen von Karen King
| Unternehmen | Position | Beginn |
|---|
Ehemalige bekannte Positionen von Karen King
| Unternehmen | Position | Ende |
|---|---|---|
| ALCON, INC. | Investor Relations Kontakt | 01.01.2022 |
| LIVANOVA PLC | Investor Relations Kontakt | 01.07.2018 |
| HOSPIRA, INC. | Investor Relations Kontakt | 01.01.2015 |
| PERDOCEO EDUCATION CORPORATION | Public Communications Contact | 01.01.2008 |
Ausbildung von Karen King
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Perdoceo Education Corp.
Perdoceo Education Corp. Other Consumer ServicesConsumer Services Offers educational services in career oriented disciplines | Consumer Services |
Alcon AG
Alcon AG Medical SpecialtiesHealth Technology Develops, manufactures and distributes surgical & eye care devices | Health Technology |
Hospira, Inc.
Hospira, Inc. Pharmaceuticals: MajorHealth Technology Provides drugs, IV sets and clinical integration & software, infusion pumps and implementation services | Health Technology |
Indiana University
Indiana University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
LivaNova Plc
LivaNova Plc Medical SpecialtiesHealth Technology Develops electrotherapeutic devices | Health Technology |
















